ALK-Abelló
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (41)
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65
Started: 9/1/2025
A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis
Started: 4/7/2021
A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis
Started: 5/10/2021
A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber
Started: 11/4/2019
Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)
Started: 1/1/2013
A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067)
Started: 6/1/2011
A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)
Started: 11/1/2011
House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma
Started: 8/1/2011
A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet
Started: 10/1/2011
Efficacy and Safety Trial of Pangramin SLIT HDM-mix in Subjects With House Dust Mite Induced Rhinitis
Started: 10/1/2009
Intraseasonal Short-time Up-dosing With Alutard SQ Grasses
Started: 4/1/2008
A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine
Started: 9/1/2008
A Phase III Trial Assessing the Pharmacodynamic Effect and the Tolerability of Grazax Treatment
Started: 4/1/2008
A Dose-Ranging Study of the Safety and Effectiveness of MK-8237 in the Treatment of House Dust Mite (HDM) Induced Allergic Rhinitis/Rhinoconjunctivitis in Adults (MK-8237-003/P07627)
Started: 10/1/2012
Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081)
Started: 11/1/2009
Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05234)
Started: 9/1/2009
Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History of Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (Study P05233)(COMPLETED)
Started: 9/1/2009
A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber
Started: 6/1/2015
Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber
Started: 6/1/2014
Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense
Started: 8/1/2011
An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy
Started: 6/1/2011
An Open Trial to Assess the Tolerability of AVANZ® Salsola Immunotherapy
Started: 12/1/2013
An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy
Started: 12/1/2011
An Open Trial to Assess the Tolerability of AVANZ® Cupressus Immunotherapy
Started: 4/1/2014
A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy
Started: 11/1/2012
A Dose-response Evaluation of ALK (the Sponsor) Tree Allergy Immunotherapy Tablet
Started: 8/1/2012
An Open Trial to Assess the Tolerability of AVANZ Olive Immunotherapy
Started: 9/1/2012
Efficacy and Tolerability of Two Different Administration Routes With SLITonePLUS Birch
Started: 1/1/2010
Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic Patients
Started: 2/1/2009
Comparison of Different Up-dosing Schedules With Osiris
Started: 12/1/2010
Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy
Started: 9/7/2022
Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008)
Started: 10/1/2012
Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX®
Started: 9/1/2009
Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate
Started: 4/1/2013
Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)
Started: 10/1/2014